INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol.15, no.1, 2011 (SCI-Expanded)
Objectives: Crimean-Congo hemorrhagic fever (CCHF) is a lethal hemorrhagic disease. There is currently no specific antiviral therapy for CCHF approved for use in humans. In this study we aimed to investigate the effect of oral ribavirin treatment on the viral load and disease progression in CCHF.